Tullos, J. B., Stoudenmire, L. L., & Pouliot, J. D. (2018). Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Hosp Pharm.
Chicago Style CitationTullos, Jordan Brooke, Laura Leigh Stoudenmire, i Jonathon David Pouliot. "Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae." Hosp Pharm 2018.
Cita MLATullos, Jordan Brooke, Laura Leigh Stoudenmire, i Jonathon David Pouliot. "Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae." Hosp Pharm 2018.